Controversies arising from recent FDOPA articles/Reply
TO THE EDITOR: In three recent articles, Dhawan et al.(1), Ishikawa et al.(2) and Wahl and
Nahmias (3) examined the use of the tracer FDOPA to quantify the decarboxylation of DOPA …
Nahmias (3) examined the use of the tracer FDOPA to quantify the decarboxylation of DOPA …
[CITATION][C] Controversies Arising from Recent FDOPA Articles—Reply
V Dhawan, T Ishikawa, C Patlak… - Journal of Nuclear …, 1997 - Soc Nuclear Med
F-DOPA in positron tomography as a tracer for DOPA decarboxylase activity and wish to
thank Drs. Gumming, Gjedde and Reith for their interest, however critical, in our work and to …
thank Drs. Gumming, Gjedde and Reith for their interest, however critical, in our work and to …
18F-DOPA PET and PET/CT
C Nanni, S Fanti, D Rubello - Journal of Nuclear Medicine, 2007 - Soc Nuclear Med
In the study of Timmers et al.(1) published in this issue of The Journal of Nuclear Medicine,
11 patients with pheochromocytoma and extraadrenal abdominal paraganglioma were …
11 patients with pheochromocytoma and extraadrenal abdominal paraganglioma were …
[PDF][PDF] Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies
DC Yu, SC Huang, ST Grafton… - Journal of Nuclear …, 1993 - Soc Nuclear Med
METhOD Theory In order to accurately estimate the uptake constant of FDOPA in the
putamen, factors such as object size, imaging resolution and background level (ie, uptake …
putamen, factors such as object size, imaging resolution and background level (ie, uptake …
FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa
WD Brown, MD Taylor, AD Roberts, TR Oakes… - Neurology, 1999 - AAN Enterprises
Objective: To evaluate the visible and quantitative anatomic distribution of fluorine-18–
labeled l-DOPA in the healthy human brain, to thereby expand the understanding of …
labeled l-DOPA in the healthy human brain, to thereby expand the understanding of …
Nigrostriatal dopaminergic imaging with iodine-123-(beta) CIT-FP/SPECT and fluorine-18-FDOPA/PET/Reply
G Tissingh, P Bergmans… - The Journal of …, 1997 - search.proquest.com
TO THE EDITOR: We read with great interest the study by Ishikawa et al. on SPECT and PET
imaging of the dopamine transporter (l). They examined 12 patients with Parkinson's …
imaging of the dopamine transporter (l). They examined 12 patients with Parkinson's …
Visualization of the gall bladder on F-18 FDOPA PET imaging: a potential pitfall
KK Balan - Clinical nuclear medicine, 2005 - journals.lww.com
The ability to label dihydroxyphenylalanine (DOPA) with the positron-emitting isotope F-18
has helped to identify the deficiency of dopamine synthesis and storage within presynaptic …
has helped to identify the deficiency of dopamine synthesis and storage within presynaptic …
[PDF][PDF] Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects
FJG Vingerhoets, BJ Snow, M Schulzer… - Journal of Nuclear …, 1994 - Soc Nuclear Med
Fluorune-18-6-fluorodopa (FD) positronemisalontomography (PET) is established for
measuring nigrostriatal dopaminergic function. This is despite the absence of data on the …
measuring nigrostriatal dopaminergic function. This is despite the absence of data on the …
[PDF][PDF] Combined FDOPA and 3OMFD PET studies in Parkinson's disease
V Dhawan, T Ishikawa, C Patlak, T Chaly… - Journal of Nuclear …, 1996 - Soc Nuclear Med
PET has been used to quantify striatal 6-@ 8FJfluoro-L-dopa (FDOPA) uptake as a measure
of presynaptic dopaminerg@ cfunction. It has been suggested that the estimation of dopa …
of presynaptic dopaminerg@ cfunction. It has been suggested that the estimation of dopa …
Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
L Wahl, C Nahmias - Journal of Nuclear Medicine: Official …, 1996 - europepmc.org
Methods The kinetics of F-Dopa in striatum were measured with PET from 0 to 150 min after
an intravenous bolus injection of tracer in four normal subjects and two patients suffering …
an intravenous bolus injection of tracer in four normal subjects and two patients suffering …